CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

3.330

+0.050 (1.52%)

At close: Oct 7, 2025, 4:00 PM EDT

3.291

-0.039 (-1.16%)

After-hours: Oct 7, 2025, 7:43 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2013 - 2019
Probody Therapeutics	138.10M	Log In	Log In	Log In	Log In	Upgrade
Probody Therapeutics Growth	36.45%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2013 - 2019
United States	138.10M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	36.45%	Log In	Log In	Log In	Log In	Upgrade